The path to artificial superintelligence
Imagine a healthcare system made up of multiple AI agents: one that manages symptom assessment, another scheduling, a third insurance, and a fourth pharmacy. Each is an expert in its domain. But they all have their own distinct knowledge and objectives. Today they can exchange data, but they are not yet able to actually coordinate…
Record details
Published: 27 July 2026
Source: MIT Technology Review
Category: News
Topics: Healthcare · Agents & autonomy · Biotech
Retrieved: 28 July 2026
Related evidence
These records share source-supplied organisations, an exact publisher byline, automatic topics or regions. The reason is shown on every link; related does not mean supporting, agreeing with or verifying this record.
Closing the data loop in AI-driven drug discovery
MIT Technology Review · 27 July 2026
How AI helps scientists design the next generation of medicines
MIT Technology Review · 23 July 2026
Pathos Picks Up Two Cancer Drugs Poised for Clinical Development With AI Agents
MedCity News AI · 4 August 2026
Scaling AI agents with trustworthy data
MIT Technology Review · 12 August 2026
The world’s largest ‘biological datacenter’ could help make animal testing obsolete
Fast Company Tech · 13 August 2026
The foundational elements of AI architecture that IT leaders need to scale
MIT Technology Review · 7 July 2026
How to cite this record
ethics.ai (27 July 2026), “The path to artificial superintelligence,” evidence record 13752, https://ethics.ai/record/13752 (originally published by MIT Technology Review).
Use and limitations
This page is a stable index and citation surface for a source record. ethics.ai did not author the underlying report and has not independently verified every claim. Automatic topics may be imperfect. For consequential use, quote and cite the original publisher.